Mantle cell lymphoma (MCL) is an aggressive and often-relapsing disease characterized by the clonal proliferation of CD5+ antigen-naive pre-germinal center B cells that form solid tumors and also enter the peripheral blood through a process called leukemization. This evidence concerns the gene CD5 and mantle cell lymphoma.